Qiagen NV | QIA - Ebitda


Qiagen NV reported $249.69M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
argenx SE USD 387.05M 99.02M Sep/2025
Avita Medical AUD -9.69M 12.21M Dec/2025
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
Moderna USD -790M 582M Dec/2025
Organon & Co USD 383M 135M Dec/2025
Qiagen NV USD 249.69M 56.53M Dec/2025
Revvity USD 248.91M 48.52M Dec/2025
Tectonic Therapeutic USD -21.18M 365K Dec/2025
Viatris USD 1B 151.5M Dec/2025
Xeris Pharmaceuticals USD 25.09M 7.67M Dec/2025